During this segment, Michael Kolodziej, MD, and Ted Okon, MBA, discuss Accountable Care Organizations (ACOs) and the variables that need to be considered when applying these models to oncology practices.
Currently, there is a need to determine a better way to measure performance, suggest the experts. ACOs, explains Mr Okon, were established to base reimbursement on performance. Providers are judged on how well they perform their roles, but their performance against other practices has not been considered, he says. Additionally, providers have done their best to improve efficiency; however, practices that are already efficient do not receive a benefit for maintaining this efficiency. Mr Okon adds that ACOs do not take into account the high costs of treatments for cancer, which adds pressure to providers to keep costs down while making important treatment decisions for their patients.
To improve the efficiency of ACO models in oncology, Dr Kolodziej and Mr Okon suggest the importance of providing more coordinated care, increasing communication, and focusing on the needs of patients. Mr Okon notes that various groups recognize these issues, are analyzing them, and are beginning to provide recommendations on how to improve ACOs.
Additionally, Dr Kolodziej is hopeful that under ACO models, hospitals will begin to establish methodologies for measuring performance and fostering continuous quality improvement.
Watch our related Peer Exchange, Oncology Stakeholders Summit, Spring 2015
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More